AstraZeneca PLC AZN shares inched down 0.99% to £117.80 Friday, on what proved to be an all-around rough trading session for ...

Shares of AstraZeneca PLC AZN inched up 0.35% to £118.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.91% to 8,328.

DelveInsight's Nontuberculous Mycobacterial Infection Market Insights report includes a comprehensive understanding of ...

In response, AstraZeneca issued a statement saying, "We are aware that a small number of our employees in China are under investigation, but we have no further information to share at this time." ...

A spokesman for AstraZeneca said: “We are aware a small number of our employees in China are under investigation and we have no further information to share at this point.” It threatens to cast a ...

A spokesman for AstraZeneca said: “We are aware a small number of our employees in China are under investigation and we have no further information to share at this point.” It threatens to ...

An AstraZeneca Plc unit settled a federal patent-infringement lawsuit with a Samsung Biologics Co. subsidiary after failing to block its biosimilar version of the $500,000-per-patient drug Soliris.

Berenberg Bank analyst Luisa Hector maintained a Buy rating on AstraZeneca (AZN – Research Report) yesterday and set a price target of $99.00. The company’s shares closed last Friday at $87.62.

Carillon Eagle Growth & Income Fund highlighted stocks like AstraZeneca PLC (NASDAQ:AZN) in the second quarter 2024 investor letter. AstraZeneca PLC (NASDAQ:AZN) is a biopharmaceutical company ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other 52-week high stocks. The U.S. stock market has been on a roll, with major indices ...

AstraZeneca has built its leading presence in ... and make sure their analysis is clear and in no way misleading or deceptive. To further protect the integrity of our editorial content, we keep ...

As noted, there is no shortage of competition awaiting her in WWE, on any of the three brands, and she will be tested in all the ways — both in-ring and on the mic. She’s shown she can hold ...